The CloudUPDRS smartphone software in Parkinson’s study: cross-validation against blinded human raters
Abstract Digital assessments of motor severity could improve the sensitivity of clinical trials and personalise treatment in Parkinson’s disease (PD) but have yet to be widely adopted. Their ability to capture individual change across the heterogeneous motor presentations typical of PD remains inade...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-12-01
|
Series: | npj Parkinson's Disease |
Online Access: | https://doi.org/10.1038/s41531-020-00135-w |
id |
doaj-dbd853c5a047468e8202a0decd920ae5 |
---|---|
record_format |
Article |
spelling |
doaj-dbd853c5a047468e8202a0decd920ae52020-12-13T12:41:25ZengNature Publishing Groupnpj Parkinson's Disease2373-80572020-12-01611810.1038/s41531-020-00135-wThe CloudUPDRS smartphone software in Parkinson’s study: cross-validation against blinded human ratersAshwani Jha0Elisa Menozzi1Rebecca Oyekan2Anna Latorre3Eoin Mulroy4Sebastian R. Schreglmann5Cosmin Stamate6Ioannis Daskalopoulos7Stefan Kueppers8Marco Luchini9John C. Rothwell10George Roussos11Kailash P. Bhatia12Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of NeurologyDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of NeurologyDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of NeurologyDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of NeurologyDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of NeurologyDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of NeurologyBirkbeck College, University of LondonBirkbeck College, University of LondonBirkbeck College, University of LondonBenchmark Performance LtdDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of NeurologyQueen Square Movement Disorders Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of NeurologyDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of NeurologyAbstract Digital assessments of motor severity could improve the sensitivity of clinical trials and personalise treatment in Parkinson’s disease (PD) but have yet to be widely adopted. Their ability to capture individual change across the heterogeneous motor presentations typical of PD remains inadequately tested against current clinical reference standards. We conducted a prospective, dual-site, crossover-randomised study to determine the ability of a 16-item smartphone-based assessment (the index test) to predict subitems from the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale part III (MDS-UPDRS III) as assessed by three blinded clinical raters (the reference-standard). We analysed data from 60 subjects (990 smartphone tests, 2628 blinded video MDS-UPDRS III subitem ratings). Subject-level predictive performance was quantified as the leave-one-subject-out cross-validation (LOSO-CV) accuracy. A pre-specified analysis classified 70.3% (SEM 5.9%) of subjects into a similar category to any of three blinded clinical raters and was better than random (36.7%; SEM 4.3%) classification. Post hoc optimisation of classifier and feature selection improved performance further (78.7%, SEM 5.1%), although individual subtests were variable (range 53.2–97.0%). Smartphone-based measures of motor severity have predictive value at the subject level. Future studies should similarly mitigate against subjective and feature selection biases and assess performance across a range of motor features as part of a broader strategy to avoid overly optimistic performance estimates.https://doi.org/10.1038/s41531-020-00135-w |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ashwani Jha Elisa Menozzi Rebecca Oyekan Anna Latorre Eoin Mulroy Sebastian R. Schreglmann Cosmin Stamate Ioannis Daskalopoulos Stefan Kueppers Marco Luchini John C. Rothwell George Roussos Kailash P. Bhatia |
spellingShingle |
Ashwani Jha Elisa Menozzi Rebecca Oyekan Anna Latorre Eoin Mulroy Sebastian R. Schreglmann Cosmin Stamate Ioannis Daskalopoulos Stefan Kueppers Marco Luchini John C. Rothwell George Roussos Kailash P. Bhatia The CloudUPDRS smartphone software in Parkinson’s study: cross-validation against blinded human raters npj Parkinson's Disease |
author_facet |
Ashwani Jha Elisa Menozzi Rebecca Oyekan Anna Latorre Eoin Mulroy Sebastian R. Schreglmann Cosmin Stamate Ioannis Daskalopoulos Stefan Kueppers Marco Luchini John C. Rothwell George Roussos Kailash P. Bhatia |
author_sort |
Ashwani Jha |
title |
The CloudUPDRS smartphone software in Parkinson’s study: cross-validation against blinded human raters |
title_short |
The CloudUPDRS smartphone software in Parkinson’s study: cross-validation against blinded human raters |
title_full |
The CloudUPDRS smartphone software in Parkinson’s study: cross-validation against blinded human raters |
title_fullStr |
The CloudUPDRS smartphone software in Parkinson’s study: cross-validation against blinded human raters |
title_full_unstemmed |
The CloudUPDRS smartphone software in Parkinson’s study: cross-validation against blinded human raters |
title_sort |
cloudupdrs smartphone software in parkinson’s study: cross-validation against blinded human raters |
publisher |
Nature Publishing Group |
series |
npj Parkinson's Disease |
issn |
2373-8057 |
publishDate |
2020-12-01 |
description |
Abstract Digital assessments of motor severity could improve the sensitivity of clinical trials and personalise treatment in Parkinson’s disease (PD) but have yet to be widely adopted. Their ability to capture individual change across the heterogeneous motor presentations typical of PD remains inadequately tested against current clinical reference standards. We conducted a prospective, dual-site, crossover-randomised study to determine the ability of a 16-item smartphone-based assessment (the index test) to predict subitems from the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale part III (MDS-UPDRS III) as assessed by three blinded clinical raters (the reference-standard). We analysed data from 60 subjects (990 smartphone tests, 2628 blinded video MDS-UPDRS III subitem ratings). Subject-level predictive performance was quantified as the leave-one-subject-out cross-validation (LOSO-CV) accuracy. A pre-specified analysis classified 70.3% (SEM 5.9%) of subjects into a similar category to any of three blinded clinical raters and was better than random (36.7%; SEM 4.3%) classification. Post hoc optimisation of classifier and feature selection improved performance further (78.7%, SEM 5.1%), although individual subtests were variable (range 53.2–97.0%). Smartphone-based measures of motor severity have predictive value at the subject level. Future studies should similarly mitigate against subjective and feature selection biases and assess performance across a range of motor features as part of a broader strategy to avoid overly optimistic performance estimates. |
url |
https://doi.org/10.1038/s41531-020-00135-w |
work_keys_str_mv |
AT ashwanijha thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters AT elisamenozzi thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters AT rebeccaoyekan thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters AT annalatorre thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters AT eoinmulroy thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters AT sebastianrschreglmann thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters AT cosminstamate thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters AT ioannisdaskalopoulos thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters AT stefankueppers thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters AT marcoluchini thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters AT johncrothwell thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters AT georgeroussos thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters AT kailashpbhatia thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters AT ashwanijha cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters AT elisamenozzi cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters AT rebeccaoyekan cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters AT annalatorre cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters AT eoinmulroy cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters AT sebastianrschreglmann cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters AT cosminstamate cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters AT ioannisdaskalopoulos cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters AT stefankueppers cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters AT marcoluchini cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters AT johncrothwell cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters AT georgeroussos cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters AT kailashpbhatia cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters |
_version_ |
1724384349881630720 |